ID: ALA2393333

Max Phase: Preclinical

Molecular Formula: C11H9N3

Molecular Weight: 183.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNc1ccnc2cc(C#N)ccc12

Standard InChI:  InChI=1S/C11H9N3/c1-13-10-4-5-14-11-6-8(7-12)2-3-9(10)11/h2-6H,1H3,(H,13,14)

Standard InChI Key:  UQZQSIKSQJXMAU-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 183.21Molecular Weight (Monoisotopic): 183.0796AlogP: 2.15#Rotatable Bonds: 1
Polar Surface Area: 48.71Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.89CX LogP: 1.46CX LogD: 1.45
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.74Np Likeness Score: -1.28

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source